Profile
F.
Michael Yakes worked as a Senior Director at Exelixis, Inc. from 2012 to 2012.
Prior to that, he worked as a Senior Director-Translational Biology at Cleave Therapeutics, Inc. Yakes holds a doctorate degree from Wayne State University (Michigan) and an undergraduate degree from Northern Michigan University.
Former positions of F. Michael Yakes
| Companies | Position | End |
|---|---|---|
| EXELIXIS, INC. | Corporate Officer/Principal | 01/01/2012 |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Training of F. Michael Yakes
| Wayne State University (Michigan) | Doctorate Degree |
| Northern Michigan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- F. Michael Yakes
